Anti-CYP26A1 antibody (Internal) (STJ73317)
SPECIFICATIONS
ClonalityPolyclonal
HostGoat
ConjugationUnconjugated
IsotypeIgG
General Information
| Short Description | Goat polyclonal antibody anti-CYP26A1 (Internal) is suitable for use in ELISA, Immunohistochemistry and Immunocytochemistry research applications. |
| Applications | Pep-ELISA/IHC/ICC |
| Host | Goat |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 0.5 mg/mL |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Dilution Range | Peptide ELISA: antibody detection limit dilution 1:16000.IHC: Paraffin embedded Human Brain (Cortex and Cerebellum). Recommended concentration: 3.75µg/ml.ICC: ER-staining of PFA-fixed and TX100-treated HeLa cells. Recommended concentration: |
| Formulation | 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Storage Instruction | Store at-20°C on receipt and minimise freeze-thaw cycles. |
Target Information
| Gene Symbol | CYP26A1 |
| Gene ID | 1592 |
| Uniprot ID | CP26A_HUMAN |
| Accession Number | NP_000774.2; NP_476498.1 |
| Immunogen Region | Internal |
| Immunogen Sequence | NLPARFTHFHGE |
| Specificity | This antibody is expected to recognize both reported isoforms (NP_000774.2; NP_476498.1) |
Additional Info
| Function | A cytochrome P450 monooxygenase involved in the metabolism of retinoates (RAs), the active metabolites of vitamin A, and critical signaling molecules in animals. RAs exist as at least four different isomers: all-trans-RA (atRA), 9-cis-RA, 13-cis-RA, and 9,13-dicis-RA, where atRA is considered to be the biologically active isomer, although 9-cis-RA and 13-cis-RA also have activity (Probable). Catalyzes the hydroxylation of atRA primarily at C-4 and C-18, thereby contributing to the regulation of atRA homeostasis and signaling. Hydroxylation of atRA limits its biological activity and initiates a degradative process leading to its eventual elimination (Probable). Involved in the convertion of atRA to all-trans-4-oxo-RA. Able to metabolize other RAs such as 9-cis, 13-cis and 9,13-di-cis RA. Can oxidize all-trans-13,14-dihydroretinoate (DRA) to metabolites which could include all-trans-4-oxo-DRA, all-trans-4-hydroxy-DRA, all-trans-5,8-epoxy-DRA, and all-trans-18-hydroxy-DRA. May play a role in the oxidative metabolism of xenobiotics such as tazarotenic acid. |
| Protein Name | Cytochrome P450 26a1Cyp26a1Cytochrome P450 Retinoic Acid-Inactivating 1Cytochrome P450raiHp450raiRetinoic Acid 4-HydroxylaseRetinoic Acid-Metabolizing Cytochrome |
| Database Links | Reactome: R-HSA-211916Reactome: R-HSA-5365859 |
| Cellular Localisation | Endoplasmic Reticulum MembranePeripheral Membrane ProteinMicrosome Membrane |
| Alternative Antibody Names | Anti-Cytochrome P450 26a1 antibodyAnti-Cyp26a1 antibodyAnti-Cytochrome P450 Retinoic Acid-Inactivating 1 antibodyAnti-Cytochrome P450rai antibodyAnti-Hp450rai antibodyAnti-Retinoic Acid 4-Hydroxylase antibodyAnti-Retinoic Acid-Metabolizing Cytochrome antibodyAnti-CYP26A1 antibodyAnti-CYP26 antibodyAnti-P450RAI1 antibody |
Information sourced from Uniprot.org